Tags |
|
|
Links |
|
|
E-Folder - Transforming Grounds
A strategic dilemma every corporation might face at some point has to do with the difficult decision of expanding its business through the acquisition of another
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
company. In many cases, this type of direct investment, like in the 2000 acquisition of Nabisco by Kraft, the second only to Swiss-based Nestle in the food worl
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
market, purchasing a business unit or an entire corporation is a strategic investment choice of major importance for all stakeholders. In fact, experienced mana
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
gers around the globe, like Kraft Chief Executive Officer Roger Deromedi, attest that a company has to investigate and evaluate the opportunity of acquiring anot
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
er company thoroughly before its Board of Directors reach such a decision.
When a marketing manager thinks of opportunity or problem tracing it is imperative to
When a marketing manager thinks of opportunity or problem tracing it is imperative to
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
begin by uncovering its overlapping characteristics. For this reason it is considered absolutely necessary to conduct what businesses refer to as "situation anal
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
ysis." This type of research is an informal study of what information is available in the specific area. It can help define the problem/opportunity and specify w
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
at additional information-if any-is needed. Such industry-related reports, like McKinsey's, are of great importance and value in order to obtain and maintain a c
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
oser look of the specifics of the industry under focus and its environment. Specifically, the industry's background and trends, the level of the industry's conso
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
lidation, customer fragmentation, technological upgrading, international market forces, the ability of a company's personnel to understand the customers' needs a
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
d the significant economies of scale, are some of the areas this report has to cover. In addition, conducting an environmental analysis and examining the socioec
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
nomic factors of the market(s) in question can assist those who are about to take a decision to identify the key success factors that have to be considered in de
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
pth and improved/expanded if the company examined is actually acquired. Also, this type of preliminary research has been also referred to as a SWOT Analysis, sin
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
e it is important to identify the strengths, weaknesses, opportunities and threats that such a business decision entails.
Later in the process, a competitive an
Later in the process, a competitive an
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
lysis has to take place so as to recognize the strengths and weaknesses of those already competing inside the specific market. As global competition has resulted
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
in a fierce competitive environment over the recent years, new product / service developments have to offer the needed "added-value" a customer wishes to receiv
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
, even before the potential buyer realizes the existence of the specific need. This differential advantage for the purchasing company can be the actual brand nam
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
, social role or excellent customer relationship status the company acquired has within its local market. Like in the case of Kraft and Nabisco, the latter had a
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
very strong brand name and enjoyed high levels of identification within the Southern Mediterranean region. By purchasing a company that has a successful history
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
and is valued by the market players, today's businessmen find themselves in highly profitable areas with the minimum amount of direct investment apart from money
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-folder.org.ua/article/44774/e-folder-Transforming-Grounds.html">Transforming Grounds</a>
BB link (for phorums):
[url=http://www.e-folder.org.ua/article/44774/e-folder-Transforming-Grounds.html]Transforming Grounds[/url]
Related Articles:
Financial Planners Publicity and Marketing - Live By The Calendar
Google As A Powerful Internet Marketing Tool
Leverage Sales Management with Emotional Intelligence - What is Your Lasting Imprint
Bookmark it:
|